Pathogenesis of membranous nephropathy: A new paradigm in evolution

Contributions to Nephrology

Volumn 181, Issue , 2013, Pages 131-142

  Glassock, Richard J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MANNOSE BINDING LECTIN; PHOSPHOLIPASE A2 RECEPTOR; PLA2R1 PROTEIN, HUMAN;

HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MEMBRANOUS GLOMERULONEPHRITIS; PHYSIOLOGY; RECURRENT DISEASE; REVIEW;

AUTOANTIBODIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY TRANSPLANTATION; MANNOSE-BINDING LECTIN; RECEPTORS, PHOSPHOLIPASE A2; RECURRENCE;

EID: 84958620054     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000348472     Document Type: Review

References (54)

1. Glassock RJ: The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010; 56:157-167.
2. Glassock RJ: Secondary membranous glo-merulonephritis. Nephrol Dial Transplant 1992; 7(suppl 1):64-71.
3. Makker SP, Tramontano A: Idiopathic membranous nephropathy: an auto-immune disease. Semin Nephrol 2011; 31:333-340.
4. Beck LH Jr, Salant DJ: Membranous ne-phropathy: recent travels and new roads ahead. Kidney Int 2010; 77:765-770.
5. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A #inf#2#/inf# receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11-21.
6. Glassock RJ: Human idiopathic membranous nephropathy-a mystery solved? N Engl J Med 2009; 361:81-83.
7. Ronco P, Debiec H: Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. J Am Soc Nephrol 2010; 21:564-569.
8. Ronco P, Debiec H: Membranous glomeru-lopathy: the evolving story. Curr Opin Nephrol Hypertens 2010; 19:254-259.
9. Lambeau G, Lazdunski M: Receptors for a growing family of secreted phospholipases A #inf#2#/inf#. Trends Pharmacol Sci 1999; 20:162-170.
10. Augert A, Payré C, de Launoit Y, Gil J, Lambeau G, Bernard D: The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep 2009; 10:271-277.
11. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Anti-phospholipase A #inf#2#/inf# receptor antibody in membranous nephropa-thy. J Am Soc Nephrol 2011; 22:1137-1143.
12. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA: An immunofluorescence test for phos-pholipase A #inf#2#/inf# receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011; 26:2526-2532.
13. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM: Antenatal membranous glo-merulonephritis due to anti-neutral endopep-tidase antibodies. N Engl J Med 2002; 346: 2053-2060. (Pubitemid 34680597)
14. Prunotto M, Carnevali ML, Candiano G, Murtas C, Bruschi M, Corradini E, Trivelli A, Magnasco A, Petretto A, Santucci L, Mattei S, Gatti R, Scolari F, Kador P, Allegri L, Ghig-geri GM: Autoimmunity in membranous ne-phropathy targets aldose reductase and SOD2. J Am Soc Nephrol 2010; 21:507-519.
15. Bruschi M, Carnevali ML, Murtas C, Candia-no G, Petretto A, Prunotto M, Gatti R, Ar-gentiero L, Magistroni R, Garibotto G, Scolari F, Ravani P, Gesualdo L, Allegri L, Ghiggeri GM: Direct characterization of target podo-cyte antigens and autoantibodies in human membranous glomerulonephritis: α-enolase and borderline antigens. J Proteomics 2011; 74:2008-2017.
16. Gitlits VM, Toh BH, Sentry JW: Disease association, origin, and clinical relevance of auto-antibodies to the glycolytic enzyme enolase. J Investig Med 2001; 49:138-145. (Pubitemid 32187087)
17. Wakui H, Imai H, Komatsuda A, Miura AB: Circulating antibodies against α-enolase in patients with primary membranous nephropathy. Clin Exp Immunol 1999; 118:445-450.
18. Strauss J, Pardo V, Koss MN, Griswold W, McIntosh RM: Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. I. Studies on nature of glomerular-bound antibody and antigen identification in a patient with sickle cell disease and immune deposit glomerulonephri-tis. Am J Med 1975; 58:382-387.
19. Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschênes G, Remuzzi G, Ulinski T, Ronco P: Early-childhood membranous nephropa-thy due to cationic bovine serum albumin. N Engl J Med 2011; 364:2101-2110.
20. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ: Anti-phospholipase A #inf#2#/inf# receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6:1286-1291.
21. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cat-tran DC, Salant DJ: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011; 22:1543-1550.
22. Debiec H, Ronco P: PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
23. Svobodova B, Honsova E, Ronco P, Tesar V, Debeic H: Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-relat-ed membranous nephropathy. Nephrol Dial Transplant 2012 (E-pub ahead of print).
24. Hoxha E, Kneibler U, Stege G, Zahner D, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA: Enhanced expression of the M-type phospholipase A #inf#2#/inf# receptor in glom-eruli correlates with serum receptor antibodies in human membranous nephropathy. Kidney Int 2012; 82:797-804.
25. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Za-wadzka A, Hofstra JM, Coenen MJ, den Hei-jer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R: Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropa-thy. N Engl J Med 2011; 364:616-626.
26. Rodriguez EF, Cosio FG, Nasr SH, Sethi S, Fidler ME, Stegall MD, Grande JP, Fervenza FC, Cornell LD: The pathology and clinical features of early recurrent membranous glo-merulonephritis. Am J Transplant 2012 (E-pub ahead of print).
27. Debiec H, Martin L, Jouanneau C, Dautin G, Mesnard L, Rondeau E, Mousson C, Ronco P: Autoantibodies specific for the phospholipase A #inf#2#/inf# receptor in recurrent and de novo membranous nephropathy. Am J Transplant 2011; 11:2144-2152.
28. Kearney N, Podolak J, Matsumura L, Hough-ton D, Troxell M: Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts. Transplant Proc 2011; 43: 3743-3746.
29. Qu Z, Liu G, Li J, Wu LH, Tan Y, Zheng X, Ao J, Zhao MH: Absence of glomerular IgG4 deposition in patients with membranous ne-phropathy may indicate malignancy. Nephrol Dial Transplant 2012; 27:1931-1937.
30. Omokawa A, Komatsuda A, Nara M, Fuji-wara S, Sato R, Togashi M, Okuyama S, Sawada KI, Wakui H: Distribution of glomer-ular IgG subclass deposits in patients with membranous nephropathy and anti-U1 ribo-nucleoprotein antibody. Nephrol Dial Transplant 2012; 27:1937-1941.
31. Cravedi P, Abbate M, Gagliardini E, Galbus-era M, Buelli S, Sabadini E, Marasà M, Beck LH Jr, Salant DJ, Benigni A, D'Agati V, Re-muzzi G: Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis 2011; 58:272-275.
32. Segawa Y, Hisano S, Matsushita M, Fujita T, Hirose S, Takeshita M, Iwasaki H: IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr Nephrol 2010; 25:1091-1099.
33. Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 2004; 19:574-579. (Pubitemid 38263115)
34. Kuroki A, Iyoda M, Shibata T, Sugisaki T: Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int 2005; 68:302-310. (Pubitemid 43181389)
35. Aalberse RC, Stapel SO, Schuurman J, Rispens T: Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009; 39:469-477.
36. Van der Zee JS, van Swieten P, Aalberse RC: Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monova-lency. J Immunol 1986; 137:3566-3571. (Pubitemid 17193317)
37. Van der Zee JS, van Swieten P, Aalberse RC: Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 1986; 64:415-422. (Pubitemid 16102170)
38. Hong M, Beck LH: Salant. Membranous ne-phropathy-associated anti-phospholipase A #inf#2#/inf# receptor IgG4 auto-antibodies activate the lectin complement pathway (abstract). Am Soc Nephrol 2011; 22:62A.
39. Cybulsky AV, Quigg RJ, Salant DJ: Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 2005; 289:F660-F671. (Pubitemid 41324186)
40. Penny MJ, Boyd RA, Hall BM: Permanent CD8+ T-cell depletion prevents proteinuria in active Heymann nephritis. J Exp Med 1998; 188:1775-1784. (Pubitemid 28536765)
41. Beck LH Jr: Membranous nephropathy and malignancy. Semin Nephrol 2010; 30:635-644.
42. Ponticelli C, Glassock RJ: Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010; 5:2363-2372.
43. Stahl R, Hoxha E, Fechner K: PLA2R autoan-tibodies and recurrent membranous ne-phropathy after transplantation. N Engl J Med 2010; 363:496-498.
44. Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A, Brunoi F, Radice F, Furci L, Argentiero L, Carnevali ML, Messa P, Scolari F, Sinico RA, Gesualdo L, Fervenza FC, Allegri L, Ravani P, Ghiggeri GM: Co-existence of different circulating an-ti-podocye antibodies in membranous ne-phropathy. Clin J Am Soc Nephrol 2012; 7: 1395-1400.
45. Dixon FJ, Feldman JD, Vazquez JJ: Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med 1961; 113:899-920.
46. Van der Vlag, Berden J: Lupus nephritis: role of anti-nucleosome autoantibodies. Semin Nephrol 2011; 31:376-389.
47. Whitworth JA, Leibowitz S, Kennedy MC, Cameron JS, Evans DJ, Glassock RJ, Schoen-feld LS: Absence of glomerular renal tubular epithelial antigen in membranous glomerulo-nephritis. Clin Nephrol 1976; 5:159-162.
48. Knehtl M, Debiec H, Kamgang P, Callard P, Cadranel J, Ronco P, Boffa JJ: A case of phos-pholipase A #inf#2#/inf# receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis 2011; 57:140-143.
49. Gunnarsson I, Schlumberger W, Rönnelid J: Antibodies to M-type phospholipase A #inf#2#/inf# receptor (PLA2R) and membranous lupus nephritis. Am J Kidney Dis 2012; 59:585-586.
50. Huang X, Qin W, Zhang M, Zheng C, Zeng C, Liu Z: Detection of anti-PLA2R autoanti-bodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy. Am J Med Sci 2012 (E-pub ahead of print).
51. Border WA, Ward HJ, Kamil ES, Cohen AH: Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest 1982; 69:451-461.
52. de Seigneux S, Bindi P, Debiec H, Alyanakian MA, Aymard B, Callard P, Ronco P, Aucou-turier P: Immunoglobulin deposition disease with a membranous pattern and a circulating monoclonal immunoglobulin G with charge-dependent aggregation properties. Am J Kidney Dis 2010; 56:117-121.
53. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol 2012; 23:1949-1954.
54. Beck LH Jr: Monocloanl anti-PLA2R and recurrent membranous nephropathy: another piece of the puzzle. J Am Soc Nephrol 2012; 23:1911-1913.